Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

REC facility already exceeds expectations by producing one millionth module ahead of plan before reaching full capacity.

November 3, 2010 10:34 pm | by I-Micronews | News | Comments

REC today officially opened one of the world's largest integrated wafer, cell and module manufacturing facilities in Tuas, Singapore. This milestone is the largest single investment ever made by REC, the largest clean tech investment ever made in Singapore at 2.5 billion Singapore...

Power Integrations announces strategic investment in SemiSouth Laboratories

November 3, 2010 10:34 pm | by I-Micronews | News | Comments

Clean-Tech innovators join forces in $30M partnership to accelerate development of energy-efficient power devices for solar, wind & hybrid/electric auto industries Investment to Help Spur Continued Growth of Clean-Tech Jobs in Mississippi

Teens of epileptic moms display poor school performance

November 3, 2010 9:37 pm | by EurekAlert | News | Comments

(Wiley-Blackwell) A large population-based study revealed that multiple antiepileptic drugs (AEDs) used by pregnant women to control seizures may cause poor school performance in their teenagers. The research team from Karolinska University Hospital and the University of Lund in...

TOPICS:
Advertisement

A Target for Stroke Therapy Drugs

November 3, 2010 9:35 pm | by Massachusetts Institute of Technology | News | Comments

New understanding of post-stroke neurons could transform patient treatment and recovery. A drug that aids neuron repair has improved recovery in mice by as much as 50 percent.

TOPICS:

Genetics spurs next generation of brain research

November 3, 2010 9:35 pm | by Baylor College of Medicine | News | Comments

The field of neurogenetics soared during the decade since scientists first released a draft sequence of the human genome, said leaders in the field from Baylor College of Medicine and Emory University School of Medicine in Atlanta in an overview published in the current issue of the...

TOPICS:

Actavis Encourages Consumers to Return Fentanyl Transdermal System 25 mcg/h

November 3, 2010 9:34 pm | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., Nov. 3, 2010 /- Further to its previously announced voluntary recall of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches, Actavis is encouraging consumers to return any product in their possession from the October 21, 2010 recall. Consumers with Actavis 25...

TOPICS:

Americans less healthy than English, but live as long or longer, study finds

November 3, 2010 9:33 pm | by EurekAlert | News | Comments

(RAND Corporation) Older Americans are less healthy than their English counterparts, but they live as long or even longer than their English peers, according to a new study.Researchers found that while Americans aged 55 to 64 have higher rates of chronic diseases than their peers in...

TOPICS:

BD Announces Results for 2010 Fourth Fiscal Quarter and Full Year

November 3, 2010 5:36 pm | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J., Nov. 3, 2010 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today reported quarterly revenues of $1.873 billion for the fourth fiscal quarter ended September 30, 2010, representing an increase of 1.0 percent from the...

TOPICS:
Advertisement

Cardiogenesis Reports Third Quarter 2010 Results

November 3, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Nov. 3, 2010 /- Cardiogenesis Corporation (OTCQB: CGCP), a leading developer of surgical products used in the treatment of diffuse coronary artery disease, today reported financial results for its third quarter and first nine months ended September 30, 2010. Revenue for...

TOPICS:

Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis

November 3, 2010 5:35 pm | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Nov. 3, 2010 /- The New England Journal of Medicine (NEJM) today published a study that found patients taking Afinitor® (everolimus) tablets experienced a decrease in the size of their subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated...

TOPICS:

Medicare Bidding System for Medical Equipment Plagued by Flaws, Delays, Lack of Transparency

November 3, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 3, 2010 /PRNewswire-USNewswire/ -- The inherent design flaws, long overdue announcement of winners, and lack of transparency in Medicare's controversial "competitive" bidding program for home medical equipment have made it difficult for homecare patients and providers to...

TOPICS:

Aethlon Medical to Present at the Singular Research Fifth Annual 'Best of the Uncovereds Conference'

November 3, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Nov. 3, 2010 /- Aethlon Medical, Inc. (OTC Bulletin Board: AEMD ), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it will present tomorrow at the at the Singular Research Fifth Annual "Best of the...

TOPICS:

Do we hide behind our reports? The challenge of directly communicating results to our patients

November 3, 2010 5:34 pm | by Diagnostic Imaging | News | Comments

“I hope my doctor can figure out why I've been having so much difficulty swallowing of late,” said the patient as I finished his upper GI study. During the procedure I clearly saw a large mass invading the lumen of Mr. Jones' esophagus but I kept this knowledge to myself as I made small...

TOPICS:

Atrion Corporation Declares Quarterly Cash Dividend

November 3, 2010 1:46 pm | by The Associated Press | News | Comments

The Board of Directors of Atrion Corporation (NASDAQ: ATRI) today announced its quarterly cash dividend of 42 cents per share on its outstanding shares of Common Stock. This dividend will be payable on December 15, 2010 to stockholders of record at the close of business on December 1,...

Hansen Medical loss widens in 3Q(2)

November 3, 2010 1:46 pm | by The Associated Press | News | Comments

Medical robotics company Hansen Medical Inc. said Wednesday that its loss widened slightly in the third quarter, missing Wall Street earnings expectations and sending shares lower in after-hours trading.For the period ended Sept. 30, the company posted a net loss of $12.1 million, or 23 cents...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading